Kovács A F
Department of Maxillofacial Plastic Surgery, Frankfurt University Medical School, Frankfurt am Main, Germany.
J Oral Implantol. 1998;24(2):101-9. doi: 10.1563/1548-1336(1998)024<0101:AOPROB>2.3.CO;2.
The feasibility of implant treatment in patients after oral ablative tumor surgery has not yet been investigated with consideration of the requisite high periodontal standards. A report on this topic has to deal not only with implant survival but also with implant health, bone response, soft tissue health, failure pattern, time of failure, and ease of restoration. For the assessment of an implant system, an overview must be accomplished that takes into account the different restorations used and their interaction with the implant system that was used. This study presents the Bone-Lock implant system (Howmedica Leibinger GmbH, Freiburg, Germany) in a retrospective investigation after 5 years of follow-up with special emphasis on the prosthetic restorations used following resection of oral malignancies. From early in 1990 through June 1996, we inserted 210 dental endosteal Bone-Lock implants (58 patients) after oral tumor resectioning. Included in the study were 45 patients with 162 implants and prosthetic restorations that had been loaded for 1 year (dentures retained by telescopic or bar-clip or ball attachments, implant-supported prostheses, tooth-to-implant connected bridges). Regular follow-up consisted of evaluation of the Plaque Index (Silness and Löe) and of the Sulcus Bleeding Index (Löe), measurements of pocket probing depth, implant mobility (by means of the Periotest method), bone resorption (according to X-ray findings), and a questionnaire that registered patient satisfaction. The results were evaluated for each restoration and were compared with baseline standards. The overall 5-year survival rate was 83.2%. For implants that had been in place for over 365 days, the survival rate was 93%. The investigation showed that after resection of oral malignancies, patients could be treated with dental implants and superstructures with long-term efficacy similar to that found in healthy subjects considering internationally accepted standards. Implant treatment in tumor patients appeared to offer the most positive periodontic results when use of bar-clip or telescope-retained overdentures was involved. The patient satisfaction level with the described prosthodontic treatment was satisfactory.
考虑到所需的高标准牙周条件,尚未对口腔肿瘤切除术后患者进行种植治疗的可行性进行研究。关于这一主题的报告不仅要涉及种植体的存活情况,还要涉及种植体健康、骨反应、软组织健康、失败模式、失败时间以及修复的难易程度。为了评估一种种植系统,必须完成一项概述,其中要考虑到所使用的不同修复体及其与所使用的种植系统之间的相互作用。本研究在对Bone-Lock种植系统(德国弗赖堡的豪梅迪卡·莱宾格有限公司)进行5年随访的回顾性调查中,特别强调了口腔恶性肿瘤切除术后所使用的修复体。从1990年初到1996年6月,我们在口腔肿瘤切除术后植入了210颗牙内骨内型Bone-Lock种植体(58例患者)。该研究纳入了45例患者,他们的162颗种植体及修复体已负重1年(通过套筒冠、杆卡或球附着体固位的义齿、种植体支持的修复体、牙-种植体连接桥)。定期随访包括评估菌斑指数(西尔尼斯和勒)和龈沟出血指数(勒)、测量牙周袋探诊深度、种植体松动度(采用牙周探针法)、骨吸收情况(根据X线检查结果)以及一份记录患者满意度的问卷。对每种修复体的结果进行评估,并与基线标准进行比较。5年总体存活率为83.2%。对于已植入超过365天的种植体,存活率为93%。调查表明,根据国际公认标准,口腔恶性肿瘤切除术后的患者可以接受牙种植体和上部结构治疗,其长期疗效与健康受试者相似。当使用杆卡或套筒冠固位的覆盖义齿时,肿瘤患者的种植治疗似乎能带来最积极的牙周结果。患者对所述修复治疗的满意度令人满意。